Fermelanta, Inc.

Fermelanta, Inc.

Private
NonoichiHealthcare & Life Scienceshttps://fermelanta.com

Last Round

Series A

Aug 28, 2025

Total Funding Raised

$15.1M

Company Overview

Fermelanta, Inc. is a biotechnology company that develops plant secondary metabolites using a microbial fermentation process for industrial raw materials and ingredients including medicines, cosmetics, or supplements.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Pharma Supply Chain, Clean Manufacturing, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

synthetic biologymicrobial fermentationsynbioprecision fermentationbio-manufacturingcontract development and manufacturingCDMOstrain developmentplant secondary metabolitePSMsfermentation-as-a-servicepharmaceutical ingredientcosmetic ingredientnutraceutical ingredientsustainable ingredientalkaloidcannabinoid

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fermelanta, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fermelanta, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AAug 28, 2025
SeedJun 13, 2023

Key People

Founding team and executive leadership

Shogo Fukizaki

Co-Founder CEO

Founding Team

Akira Nakagawa

Chief Technology Officer

Executive Team

Fermelanta, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2027

    Construction of a commercial-scale mass-production plant to begin in early 2027.

  • May 1, 2026

    3kL pilot plant construction to be completed by May 2026.

Fermelanta, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fermelanta, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fermelanta, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNonoichi
Employee Range16
Year Founded2022
Last FundingAug 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.